Integrin
Signaling Pathway Map
Research Area
- Inhibitory Selectivity
- Solubility
| Catalog No. | Product Name | Solubility(25°C) | ||
|---|---|---|---|---|
| Water | DMSO | Alcohol | ||
| S7077 | Cilengitide trifluoroacetate | 8 mg/mL | 100 mg/mL | <1 mg/mL |
| S8008 | RGD (Arg-Gly-Asp) Peptides | 12 mg/mL | <1 mg/mL | <1 mg/mL |
| S2885 | A-205804 | <1 mg/mL | 60 mg/mL | <1 mg/mL |
| S7540 | SB273005 | <1 mg/mL | 90 mg/mL | 16 mg/mL |
| S7834 | Cyclo (-RGDfK) | 84 mg/mL | 100 mg/mL | <1 mg/mL |
| S7844 | Cyclo(RGDyK) | 100 mg/mL | 100 mg/mL | 20 mg/mL |
| S3085 | Tirofiban | <1 mg/mL | 0.005 mg/mL | <1 mg/mL |
| S8594 | Tirofiban Hydrochloride | 95 mg/mL | 95 mg/mL | 95 mg/mL |
| S8454 | ATN-161 (Ac-PHSCN-NH2) | 13 mg/mL | -1 mg/mL | -1 mg/mL |
| S3714 | Lifitegrast | <1 mg/mL | 100 mg/mL | 20 mg/mL |
| S8306 | Leukadherin-1 | <1 mg/mL | 15 mg/mL | <1 mg/mL |
- Integrin Inhibitors (11)
| Catalog No. | Information | Product Use Citations | Product Validations |
|---|---|---|---|
| S7077 |
Cilengitide trifluoroacetateCilengitide is a potent integrin inhibitor for αvβ3 receptor and αvβ5 receptor with IC50 of 4.1 nM and 79 nM in cell-free assays, respectively; ~10-fold selectivity against gpIIbIIIa. Phase 2. |
WT mice were subjected to BDL and treated with either vehicle or cilengitide (10 mg/kg) daily for 6 days; adjacent liver sections were immunostained for CK19 or PCNA. Data were quantified and expressed as mean ± SD. (n = 6 per group.) *P < 0.02, **P < 0.004, Student’s t test.
|
|
| S8008 |
RGD (Arg-Gly-Asp) PeptidesRGD (Arg-Gly-Asp) Peptides is a cell adhesion motif which can mimic cell adhesion proteins and bind to integrins. |
BC, aMPV/B F protein fusogenic activity was determined using syncytium formation and reporter gene assays. RGE peptides (80 μM) were used as the control.
|
|
| S2885 |
A-205804A-205804 is a potent and selective inhibitor of E-selectin and ICAM-1 expression with IC50 of 20 nM and 25 nM respectively. |
MDA-MB-231 cells transfected with ICAM-1-specific siRNAs or treated for 12 h with A-205804 at the indicated concentrations were subjected to immunoblotting with indicated antibodies. Densitometric data (fold) were shown below each group.
|
|
| S7540 |
SB273005SB273005 is a potent integrin inhibitor with Ki of 1.2 nM and 0.3 nM for αvβ3 receptor and αvβ5 receptor, respectively. |
||
| S7834 |
Cyclo (-RGDfK)Cyclo (-RGDfK) is a potent and selective αvβ3 integrin inhibitor. |
||
| S7844 |
Cyclo(RGDyK)Cyclo(RGDyK) is a potent and selective αVβ3 integrin inhibitor with IC50 of 20 nM. |
||
| S3085 |
TirofibanTirofiban (MK-383) is a selective platelet GPIIb/IIIa antagonist which inhibits platelet aggregation with IC50 of 9 nM. |
||
| S8594 |
Tirofiban HydrochlorideTirofiban Hydrochloride is the hydrochloride salt form of tirofiban, a selective platelet GPIIb/IIIa antagonist which inhibits platelet aggregation. It is more soluable than Tirofiban. |
||
| S8454 |
ATN-161 (Ac-PHSCN-NH2)ATN-161 (Ac-PHSCN-NH2) is a novel small peptide antagonist of integrin α5β1. It binds to several integrins, including α5β1 and αvβ3, that play a role in angiogenesis and tumor progression. |
||
| S3714 |
LifitegrastLifitegrast is a novel small molecule integrin antagonist that inhibits a specific T cell-mediated inflammatory pathway involved in the pathogenesis of DED. |
||
| S8306 |
Leukadherin-1Leukadherin-1 (LA1) is a small molecule agonist that enhances CD11b/CD18-dependent cell adhesion to its ligand ICAM-1(an agonist for the complement receptor 3 (CD11b/CD18)). |
